PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 170762

[Uremic polyneuropathies].

V I Shumakov·E R Levitskiĭ·B D Verkhovskiĭ·A I Reznikova
View original source ↗Export metadata ↓

Abstract

The report is concerned with the results of a study of polyneuropathy in 75 patients with acute and chronic renal insufficiency. The authors described the clinical characteristics of the different forms of neuropathy. In acute renal insufficiency the first signs of polyneuropathy appear during the stage of polyuria and are reversible. In chronic renal insufficiency and hemodialysis treatment of subclinical an sensory forms of neuropathy are mainly seen (2/3 of the patients). It was demonstrated that there was a retardation in the velocity of excitative conductivity through the nerves depending upon the severity of polyneuropathy. A longterm adequate hemodialysis may prevent the further development of polyneuropathy.

Explore related subjects

Acute Kidney InjuryAdolescentAdultChronic DiseaseElectromyographyFemaleGlomerulonephritisHumansKidney Failure, ChronicMaleNeural ConductionNeurologic ManifestationsOliguriaReflex, StretchRenal DialysisSensationSynaptic TransmissionUremiaEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V I Shumakov, E R Levitskiĭ, B D Verkhovskiĭ, A I Reznikova. 1975. [Uremic polyneuropathies].. https://pubmed.ncbi.nlm.nih.gov/170762/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2013

The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics.

Early transplant dysfunction and failure because of immunological and nonimmunological factors still presents a significant clinical problem for transplant recipients. A critical unmet need is the noninvasive detection and prediction of immune injury such that acute injury can be reversed by proactive immunosuppression titration. In this study, we used iTRAQ -based proteomic discovery and targeted ELISA validation to discover and validate candidate urine protein biomarkers from 262 renal allograft recipients with biopsy-confirmed allograft injury. Urine samples were randomly split into a training set of 108 patients and an independent validation set of 154 patients, which comprised the clinical biopsy-confirmed phenotypes of acute rejection (AR) (n = 74), stable graft (STA) (n = 74), chronic allograft injury (CAI) (n = 58), BK virus nephritis (BKVN) (n = 38), nephrotic syndrome (NS) (n = 8), and healthy, normal control (HC) (n = 10). A total of 389 proteins were measured that displayed differential abundances across urine specimens of the injury types (p < 0.05) with a significant finding that SUMO2 (small ubiquitin-related modifier 2) was identified as a "hub" protein for graft injury irrespective of causation. Sixty-nine urine proteins had differences in abundance (p < 0.01) in AR compared with stable graft, of which 12 proteins were up-regulated in AR with a mean fold increase of 2.8. Nine urine proteins were highly specific for AR because of their significant differences (p < 0.01; fold increase >1.5) from all other transplant categories (HLA class II protein HLA-DRB1, KRT14, HIST1H4B, FGG, ACTB, FGB, FGA, KRT7, DPP4). Increased levels of three of these proteins, fibrinogen beta (FGB; p = 0.04), fibrinogen gamma (FGG; p = 0.03), and HLA DRB1 (p = 0.003) were validated by ELISA in AR using an independent sample set. The fibrinogen proteins further segregated AR from BK virus nephritis (FGB p = 0.03, FGG p = 0.02), a finding that supports the utility of monitoring these urinary proteins for the specific and sensitive noninvasive diagnosis of acute renal allograft rejection.

Acute Kidney Injury↗
PubMed2004

Non-parametric estimation of gap time survival functions for ordered multivariate failure time data.

Times between sequentially ordered events (gap times) are often of interest in biomedical studies. For example, in a cancer study, the gap times from incidence-to-remission and remission-to-recurrence may be examined. Such data are usually subject to right censoring, and within-subject failure times are generally not independent. Statistical challenges in the analysis of the second and subsequent gap times include induced dependent censoring and non-identifiability of the marginal distributions. We propose a non-parametric method for constructing one-sample estimators of conditional gap-time specific survival functions. The estimators are uniformly consistent and, upon standardization, converge weakly to a zero-mean Gaussian process, with a covariance function which can be consistently estimated. Simulation studies reveal that the asymptotic approximations are appropriate for finite samples. Methods for confidence bands are provided. The proposed methods are illustrated on a renal failure data set, where the probabilities of transplant wait-listing and kidney transplantation are of interest.

Acute Kidney Injury↗